Work

Primary Cutaneous NK /T‐Cell Lymphoma With Aberrant CD20 Expression Responsive to SMILE Chemotherapy

Year: 2025
Type: article
Abstract: The authors declare no conflicts of interest. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Language: English
Subfield: Dermatology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4416441355
FWCI:
Cites: 8
Cited by:
Related to: